High doses of vitamin D may not affect COVID-19 severity or number of hospital visits, however, it may slightly reduce the ...

Introduction Infectious diarrhoea causes millions of deaths annually in low-income countries. Prevention strategies ...

While vitamin D3 does not improve immediate COVID-19 outcomes or reduce medical visits, it may lower the risk of developing ...

BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ...

AI hasn't eliminated bottlenecks. It has relocated them from execution to judgment: strategy, synthesis, architectural ...

While a randomized controlled trial of vitamin D 3 supplementation in COVID-19 patients didn’t yield a significant reduction ...

Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...

BioVersys receives US FDA nod to recruit US patients for BV100 HABP/VABP phase 3 trial to treat hospital-acquired or ventilator-associated bacterial pneumonia: Basel, Switzerland ...

High-dose Vitamin D doesn't reduce acute COVID severity but shows a promising signal for reducing Long COVID and brain fog.

WallabyPhenox is preparing to initiate PIANO , a landmark U.S. clinical trial designed to expand access to flow diversion therapy within one of the fastest-growing segments of the neurovascular market ...

A single peer-led Brief Alcohol Screening and Intervention for College Students (BASICS) session resulted in a reduction in weekly alcohol consumption by more than three drinks at 12 months among ...

The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for ...